BridgeMD
New treatment option for Leptospirosis
Official title Chronic Post-leptospirosis Manifestations in Reunion
ClinicalTrials.gov ID: NCT05436756
What this study is testing
- What it's testing
- Leptospirosis is a zoonosis caused by spirochetes, pathogenic bacteria of the genus Leptospira. It is transmitted to humans through mucocutaneous lesions by contact with water or soil contaminated by the urine of animal reservoirs (rats, dogs, pigs, cattle, etc.).
- Time commitment: about 1 year
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Adults
You may be able to join if
- Adult or child people having been included in the COLEPT cohort with confirmed leptospirosis Where
- Adult people or children hospitalized for leptospirosis confirmed within 12-18 months before LEPTONIC inclusion;
- Be resident in Reunion
- Ability to answer a telephone questionnaire
- Benefit from a social security scheme
You likely can't join if
- Refusal of participation by the patient or his entourage if the patient is physically unable to give his opinion (coma, resuscitation, etc.).
- Exclusion or premature termination of participation in the COLEPT cohort
- Patient under judicial safeguard, guardianship or curatorship, under activated future protection mandate and family authorization
The study team makes the final eligibility decision.
Where it's taking place
- Saint-Paul, France
- Saint-Pierre, France
- Saint-Benoît, Reunion
- Saint-Denis, Reunion
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The study runs about 1 year per participant, based on its public description. The team confirms the exact schedule and number of visits before you enroll.
Who can join this trial?
This study is enrolling all sexes, not specified. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Saint-Paul, France; Saint-Pierre, France; Saint-Benoît, Reunion; Saint-Denis, Reunion. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.